House Republicans Seek Top Down Change To FDA’s Warning-Letter Appeals
This article was originally published in The Tan Sheet
Executive Summary
FDA leadership needs to review the agency's enforcement dispute resolution process, according to ranking Republicans on the House Energy and Commerce Committee
You may also be interested in...
House Republicans Challenge FDA On Warning Letter Appeals Process
Senior Republicans on the House Energy & Commerce Committee are challenging FDA on the fairness of its warning letter appeals process, questioning whether the agency "really provides a good-faith option of appeal.
Pharmachem Gains Phase 2 Claims Agreement, Plus Patent For New Product
Pharmachem Laboratories' experience with claims for its Phase 2 starch-neutralizer branded ingredient may provide an example for firms seeking to validate claims with the FDA, the firm says